Skip to content
Navigating a New Political Landscape: View real-time updates about the impact of and Northeastern’s response to recent political changes.
Apply
Stories

Are COVID-19 vaccine trials ethical?

People in this story

Photo by Matthew Modoono/Northeastern University

As the race to create a COVID-19 vaccine speeds ahead, many people have expressed an unwillingness to receive the immunization once it’s available, arguing that the vaccine won’t have enough time to undergo proper vetting. Now, researchers fear that some of those same people won’t be interested in participating in vaccine clinical trials, illuminating a tricky catch-22—people don’t want a vaccine unless it’s been tested, but people also don’t want to be part of the tests because of the unknown risks. 

Suspicions about the vaccine development process were reinforced last week following the death of a Brazilian volunteer in an experimental trial for a COVID-19 vaccine developed by Oxford University, and produced by the pharmaceutical company AstraZeneca.  While it’s unclear whether the participant’s death was linked to the trial, the incident nonetheless sowed doubt among an already dubious section of the population, as reflected in the subsequent downturn in AstraZeneca shares

Continue reading at News@Northeastern.

More Stories

Laurel and Scroll 100 honors outstanding graduate students for achievements aligning with the university’s mission, ideals and values. Photo by Matthew Modoono/Northeastern University

Northeastern honors top graduate students with launch of Laurel and Scroll 100 Society

04.15.2025
Eli Curwin sits at his laptop

From City Hall to Congress, Northeastern co-op student finds his voice on Mayor Wu’s speechwriting team

04.15.2025
President Donald Trump, left, greets Nayib Bukele, President of El Salvador, outside the White House on Monday, April 14, 2025.

Did Donald Trump defy a Supreme Court order to return Kilmar Abrego Garcia?

04.15.25
All Stories